Cryptococcal Meningitis Manifesting As a Large Abdominal Cyst in a HIV-infected Patient with a CD4 Count Greater Than 400 Cells/mm(3)
Overview
Overview
Journal
AIDS Patient Care STDS
Specialty
Infectious Diseases
Date
2008 Apr 1
PMID
18373418
Citations
1
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Cryptococcal meningitis usually occurs among HIV-positive patients with CD4 counts less than 100 cells/mm(3) and manifests as headaches, fevers, and mental status changes. We present an unusual case of cryptococcal meningitis in a 34-year-old HIV-positive man presenting as a large abdominal cyst at the ventriculoperitoneal shunt site despite receiving highly active antiretroviral therapy (HAART) for more than 5 years and having a CD4 count more than 400 cells/mm(3).
Citing Articles
Dhitinanmuang W, Chongtrakool P, Jitmuang A BMC Infect Dis. 2018; 18(1):257.
PMID: 29866070 PMC: 5987493. DOI: 10.1186/s12879-018-3165-y.
References
1.
Bicanic T, Harrison T, Niepieklo A, Dyakopu N, Meintjes G
. Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution. Clin Infect Dis. 2006; 43(8):1069-73.
DOI: 10.1086/507895.
View
2.
van der Horst C, Saag M, Cloud G, Hamill R, Graybill J, Sobel J
. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med. 1997; 337(1):15-21.
DOI: 10.1056/NEJM199707033370103.
View
3.
Park M, Hospenthal D, Bennett J
. Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting. Clin Infect Dis. 1999; 28(3):629-33.
DOI: 10.1086/515161.
View
4.
Izumoto S, Nakagawa H, Fujita T, Kubo S
. Abdominal cyst formation following ventriculoperitoneal shunt in a case of hydrocephalus due to cryptococcal meningitis. Case report: completely cured by surgical removal of the cyst and treatment with a newly developed anti-fungal drug (Difulcan). Surg Neurol. 1991; 36(5):394-9.
DOI: 10.1016/0090-3019(91)90031-4.
View
5.
Saag M, Graybill R, Larsen R, Pappas P, Perfect J, Powderly W
. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis. 2000; 30(4):710-8.
DOI: 10.1086/313757.
View